Etanercept
Class
TNFα inhibitors
Subclass
TNF receptor / IgG1 Fc fusion protein
Substance name
Etanercept, etanercept‑szzs, etanercept‑ykro
Brand names
Enbrel®
Common formulations
Solution
Dosage and administration
Adults patients
Symptomatic relief
Axial spondyloarthritis
Treatment
Plaque psoriasis
Psoriatic arthritis
Rheumatoid arthritis • Moderate-to-severe, active
Indications for use
Labeled indications
Adults
Children
Safety risks
Boxed warnings
Immunosuppression
Infections
Malignancies
Opportunistic infections
Contraindications
Granulomatosis with polyangiitis receiving immunosuppressive agents
Latex hypersensitivity
Warnings and precautions
Autoimmune disorders
Exacerbation of HF
Hematologic abnormalities
Neurologic abnormalities
Reactivation of HBV infection
Reactivation of tuberculosis
Specific populations
Renal impairment
eGFR 0-90 mL/min/1.73 m²
Renal replacement therapy
Any modality
Hepatic impairment
Any severity
Substantial chronic alcohol consumption
Pregnancy and breastfeeding
Pregnancy
All trimesters • Australia Category: D
Breastfeeding
Unlikely to have adverse effects in breastfed infants.
Unknown amount excreted in breastmilk.
Undetectable levels in breastfed infants.
Adverse reactions
Very common > 10%
Common 1-10%
Uncommon < 1%
Unknown frequency
Interactions
Drug(s)
Check Interactions
Reset
What did you think about this content?
Sign up for free to access the full drug resource